Lori E Dodd

9PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMedical virologyMedical bacteriologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 07, 2026
Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions.

Stephanus T Malherbe, Ray Y Chen, Xiang Yu

|Dec 10, 2025
Group-Sequential Designs With an Externally-Driven Change of Primary Endpoint.

Amin Yarahmadi, Lori E Dodd, Peter Horby

|Apr 16, 2025
Tecovirimat for Clade I MPXV Infection in the Democratic Republic of Congo.

Rosine Ali, Jules Alonga, Jean-Luc Biampata

|Aug 21, 2024
Group sequential designs for clinical trials when the maximum sample size is uncertain.

Amin Yarahmadi, Lori E Dodd, Thomas Jaki

|Feb 04, 2021
Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis.

Yingda L Xie, Veronique R de Jager, Ray Y Chen

|Jul 18, 2020
Endpoints for randomized controlled clinical trials for COVID-19 treatments.

Lori E Dodd, Dean Follmann, Jing Wang

Pageof 2

Frequent Collaborators

4 joint publications

Dean Follmann

3 joint publications

Thomas Jaki

2 joint publications

Kriti Arora

2 joint publications

Jill Winter